Overview
Acurion, a San Diego-based precision oncology technology company, has successfully closed an oversubscribed $4.3 million seed financing round, surpassing its initial target of $4 million. The funding will support the development of its AI-driven biomarker detection platform, OncoGaze.
Products
Loading...
Recent Deals
Acurion, a San Diego-based precision oncology technology company, has successfully closed an oversubscribed $4.3 million seed financing round, surpassing its initial target of $4 million. The funding will support the development of its AI-driven biomarker detection platform, OncoGaze.